Answers are grounded in this paper and cite their sources.
Red blood cell antigens play critical roles in blood transfusion since donor incompatibilities can be lethal. Recipients with the rare total deficiency in H antigen, the OhBombay phenotype, can only be transfused with group Ohblood to avoid serious transfusion reactions. We discover FucOB from the mucin-degrading bacteriaAkkermansia muciniphilaas an α-1,2-fucosidase able to hydrolyze Type I, Type II, Type III and Type V H antigens to obtain the afucosylated Bombay phenotype in vitro. X-ray crystal structures of FucOB show a three-domain architecture, including a GH95 glycoside hydrolase. The structural data together with site-directed mutagenesis, enzymatic activity and computational methods provide molecular insights into substrate specificity and catalysis. Furthermore, using agglutination tests and flow cytometry-based techniques, we demonstrate the ability of FucOB to convert universal O type into rare Bombay type blood, providing exciting possibilities to facilitate transfusion in recipients/patients with Bombay phenotype.
No takes yet. Share an insight, caveat, or question.
Anso et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: